MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer.

Authors

• Renée de Leeuw
• Christopher McNair
• Matthew J Schiewer
• Neermala Poudel Neupane
• Lucas J Brand
• Michael A Augello
• Zhen Li
• Larry C Cheng
• Akihiro Yoshida
• Sean M Courtney
• E Starr Hazard
• Gary Hardiman
• Maha H Hussain
• J Alan Diehl
• Justin M Drake
• Wm Kevin Kelly
• Karen E Knudsen

Publication/Presentation Date

9-1-2018

Volume

24

Issue

17

First Page

4201

Last Page

4214

ISSN

1557-3265

Published In/Presented At

de Leeuw, R., McNair, C., Schiewer, M. J., Neupane, N. P., Brand, L. J., Augello, M. A., Li, Z., Cheng, L. C., Yoshida, A., Courtney, S. M., Hazard, E. S., Hardiman, G., Hussain, M. H., Diehl, J. A., Drake, J. M., Kelly, W. K., & Knudsen, K. E. (2018). MAPK Reliance via Acquired CDK4/6 Inhibitor Resistance in Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research, 24(17), 4201–4214. https://doi.org/10.1158/1078-0432.CCR-18-0410

Disciplines

Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods

PubMedID

29739788

Department(s)

Administration and Leadership

Document Type

Article